Evaluation for Effectiveness and Tolerance Duration of Initial Medication on Untreated Early Parkinson's Disease |
Cheon, Young Ju
(College of Pharmacy, The Catholic University of Korea)
Park, Yong Sung (Department of Radiology, Kyunghee University Hospital at Gang-dong) Kim, Jung Tae (Department of Pharmacy, Kyunghee University Hospital at Gang-dong) Lim, Sung Cil (College of Pharmacy, The Catholic University of Korea) |
1 | Siuda, J., Jasinska-Myga, B., Boczarska-Jedynak, M., Opala, G., Fiesel, F. C., Moussaud-Lamodière, E. L., Scarffe, L. A., Dawson, V. L., Ross, O. A., Springer, W., Dawson, T. M. and Wszolek, Z. K. : Early-onset Parkinson's disease due to PINK1 p.Q456X mutation - Clinical and functional study. Parkinsonism Relat. Disord. 20, 1274 (2014). DOI |
2 | 한국임상약학회 : 약물치료학 요약집 2014, 1st ed., 도서출판 신일북스. 서울 p. 402 (2014). |
3 | Cheong, H. K., Lee, C. S., Kim, Y. H., Sung, J. H., Yi, S. E., Kim, J. W., Park, J. S., Kim, E. H., Kim, J. H., Jang, M. S. and Shim, M. Y. : Nationwide survey on the prevalence of Parkinson's disease in Korea. Korea Centers for Disease Control and Prevention (2007). |
4 | Homepage of Korea Centers for Disease Control and Prevention. URL=http://www.cdc.go.kr/CDC/cms/content/37/16537_view.html. |
5 | Parkinson study group : Pramipexole vs. levodopa as initial treatment for Parkinson disease, a randomized controlled study. JAMA 284, 1931 (2000). DOI |
6 | Miyasaki, J. M., Martin, W., Suchowersky, O., Weiner, W. J. and Lang, A. E. : Practice parameter: initiation of treatment for Parkinson's disease: An evidence-based review. Neurology 58, 11 (2002). DOI |
7 | Tarsy, D. :Initial treatment of Parkinson's disease. Curr. Treat. Options Neurol. 8, 224 (2006). DOI |
8 | Connolly, B. S. and Lang, A. E. : Pharmacological treatment of Parkinson disease - A Review. JAMA 311, 1670 (2014). DOI |
9 | Tarsy, D., Hurtig, H. I. and Dashe, J. F. : Pharmacologic treatment of Parkinson disease. Uptodate, the last updated Jul (2014) URL=http://www.uptodate.com/contents/pharmacologic-treatment-of-parkinson-disease#H2. |
10 | Szewczyk-Krolikowsk, K., Tomlinson, P., Nithi, K., Wade-Martins, R., Talbot, K., Ben-Shlomo, Y. and Hu, M. T. : The influence of age and gender on motor and non-motor features of early Parkinson's disease: Initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort. Parkinsononism Relat. Disord. 20, 99 (2014). DOI |
11 | Fahn, S. : Is levodopa toxic? Neurology 47, S184 (1996). DOI |
12 | NICE (National Institute for health and Care Excellence guideline) : Parkinson's disease, NICE guidelines [CG35]. published date : June 2006, Review decision date : July 2011, URL=http://www.nice.org.uk/guidance/cg035. |
13 | Pahwa, R. and Lyons, K. E. : Early diagnosis of Parkinson's disease: Recommendations from diagnostic clinical guidelines. Am. J. Manag. Care 16, S94 (2010). |
14 | Hauser, R. A. : Early pharmacologic treatment in Parkinson's disease. Am. J. Mang. Care 16, S100 (2010). |
15 | The Parkinson Study Group : Levodopa and the progression of Parkinson's disease. N. Eng. J. Med. 351, 2498 (2004). DOI |
16 | EFNS/MDS-ES (European Federation of Neurological Societies/Movement disorder Society-European Section) guidelines : Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease. Eur. J. Neurol. 20, 5 (2013). DOI |
17 | Nutt, J. G. and Wooten, G. F. : Diagnosis and initial management of Parkinson's disease. N. Engl. J. Med. 353, 1021 (2005). DOI |
18 | Chu, M. K., Kim, W. C., Choi, J. M., Hong, J. H., Kang, S. Y., Ma, H. I. and Kim, Y. J. : Analysis of dosage mutation in PARK2 among Korean patients with early-onset or familial Parkinson's disease. J. Clin. Neurol. 10, 244 (2014). DOI |
19 | Fujio, H., Inokuchi, G., Fukuda, Y., Hasegawa, S., Ootsuki, N. and Nibu, K. : A case report of Parkinson's disease presenting with olfactory disturbance as a primary symptom in the early stage. Nihon Jibiinkoka GakkaiKaiho 117, 932 (2014). DOI |